Get 40% Off
🔥 This hedge fund gained 26.16% in the last month. Get their top stocks with our free stock ideas tool.See stock ideas

Europe stocks close lower; pharmas, commods weigh

Published 06/26/2009, 11:44 AM
Updated 06/26/2009, 12:00 PM
BP
-
SASY
-
NOVOb
-
ENRC
-
RIO
-
BHPB
-
TLW
-
ANTO
-

LONDON, June 26 (Reuters) - European shares closed lower on Friday, as drugmakers fell led by Sanofi-Aventis, while commodities retreated tracking lower crude and metal prices.

The pan-European FTSEurofirst 300 index of top shares provisionally closed down 0.3 percent at 843.49 points, having been up as much as 856.74 points earlier in the day.

"Its been a funny kind of day. The market started off well and then slipped back. It is difficult to say what it is," said Peter Dixon, strategist at Commerzbank.

"Over the course of the day sentiment has seemed to have dissippated. I also think it is a bit of a reaction to the negative day in the U.S. Investors just want to sell and take profits," Dixon said.

Major U.S. indexes were down 0.1-0.7 percent.

Drugmakers took the most points off the index. Sanofi-Aventis shares slipped 8 percent, extending the previous day's losses, while Novo Nordisk fell 3.7 percent on continuing concerns about the safety of Sanofi's diabetes drug Lantus and modern insulins in general.

Energy stocks were lower as crude fell back 1.3 percent. BP , Royal Dutch Shell and Tullow Oil slipped 0.2-0.8 percent.

Miners were in the doldrums as copper retreated 1.2 percent. Anglo American, Antofagasta, BHP Billiton, Eurasian Natural Resources Corporation and Rio Tinto were down 0.7-2 percent. (Reporting by Joanne Frearson)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.